ALFA Finder
12:07 IST
BSE
Earnings Call
Indegene Earnings Call Transcript: Key Takeaways
Strong top-line growth driven by pharma digital transformation, but near-term margins are compressed by annual wage hikes and mutual fund mark-downs.
Indegene Ltd
- Share price
- ₹616.00
- Market cap
- ₹14,841 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 36.1×Sector 54.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 2Earnings Call 2Results Update 1Other Announcement 1Merger & Restructuring 1Financial Results 1Employee Stock Options 1Business Update 1
Time
10 announcements with these filters
20:14 IST
BSE
Management Change
Indegene Management Change
Indegene's Company Secretary and Compliance Officer Srishti Ramesh Kaushik resigned, effective 02-Dec-2026. The resignation cites future career advancement.
20:13 IST
BSE
Employee Stock Options
Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
20:07 IST
BSE
Earnings Call
Indegene Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 11,223M (+39.5% YoY, +5.6% QoQ), EBITDA margin 16.7%, PAT INR 1,123M (+10% YoY). BioPharm integration ahead of plan.
20:03 IST
BSE
Results Update
Indegene Results Update
Indegene reported Q2 FY27 revenue of ₹11,223M, up 39.5% YoY, with PAT of ₹1,123M. H1 USD revenue growth reached a four-year high of 27.0%.
19:37 IST
BSE
Financial Results
Indegene Q2 FY27 Results: Net Profit ₹112.3 Cr, Up 10.0% YoY
Indegene Ltd reported revenue from operations of ₹1,122 Cr (+39.6% YoY) and net profit of ₹112.3 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹112.3 Cr · +10.0% YoY
16:28 IST
BSE
Merger & Restructuring
Indegene Merger & Restructuring
Indegene Ltd disclosed that its step-down wholly owned subsidiary, Indegene Portugal Unipessoal LDA, was incorporated on 23 October 2026. The entity has nil turnover and is yet to begin operations.
10:35 IST
NSE
Business Update
Indegene Business Update
Indegene received Frost & Sullivan's 2026 Global Enabling Technology Leadership award for AI-powered pharma commercialization. The recognition highlights its domain-led AI platform and workflow transformation capabilities.
12:39 IST
BSE
Other Announcement
Indegene Other Announcement
Indegene Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing details share distribution across promoter and public shareholder categories.
12:58 IST
BSE
Management Change
Indegene Management Change
Indegene's Non-Executive Director Mr. Mark Dzialga resigned effective October 29, 2026, following Brighton Park Capital's sale of its entire stake. No other material board changes are disclosed.